Skip to content

Scanadu Urine Device Validation Study Protocol

Scanadu Urine Device Validation Study Protocol

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02973178
Enrollment
300
Registered
2016-11-25
Start date
2016-08-31
Completion date
2016-12-31
Last updated
2016-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glucose Intolerance, Hematuria, Ketone Urine, Proteinuria, Urinary Tract Infections

Brief summary

This study will test Scanadu Urine Device for clinical performance and usability.

Detailed description

The objectives of this study are to: * Evaluate and validate the clinical performance of the Scanadu Urine Device in the hands of intended users as compared to: the visual read of chemical test strips performed by lab technicians utilizing the Siemens Multistix® 10SG technology (K905396). * Evaluate and validate the user-interface of the Scanadu Urine Device by the intended users for human factors and user interface of the Scanadu Urine Device. * Evaluate the reproducibility in the hands of the lay-users after repeated testing of samples with known test levels

Interventions

DEVICEScanadu Urine Device

Device to allow lay user to perform urinalysis test at home.

Sponsors

Scanadu, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Female and male * 18 years old or older * Pregnant or not pregnant * Must have experience using an Apple iPhone * Have no visual impairments * Able to hold Smart Phone horizontally in raised dominant hand * Must be able to read and understand English * Must provide Informed Consent

Exclusion criteria

* Has a known history of a visual impairment that may affect reading and navigating the Scanadu Urine app * Unable to void and collect urine specimen for testing * Unable to hold phone steady (horizontally) or has history of tremors or conditions such as Parkinson's disease

Design outcomes

Primary

MeasureTime frameDescription
Usability: % successful scans in three tests conducted by lay users in following the app on the iPhone and obtain user experience on questionnaireSingle visit in one dayEvaluate and validate the user-interface of the Scanadu Urine Device by the intended users for human factors and user interface of the Scanadu Urine Device.
Method Comparison: Conduct two tests by following iPhone app (self and patient samples), results in concordance with professional testers; achieve accuracy in different concentrations of six urine analytes each using approximately 20 samples per level.Single visit in one dayEvaluate and validate the clinical performance of the Scanadu Urine Device in the hands of intended users as compared to: the visual read of chemical test strips performed by lab technicians utilizing the Siemens Multistix® 10SG technology (K905396).
Reproducibility: Lay user's ability to repeat a urine test nine times by following iPhone app and obtain nine results that are in concordance.Single visit in one dayEvaluate the reproducibility in the hands of the lay-users after repeated testing of samples with known test levels

Countries

United States

Contacts

Primary ContactJenny Li
jenny.li@scanadu.com650-567-6389
Backup ContactDaya Ranamukhaarachchi
daya@scanadu.com301-569-1213

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026